Status:
COMPLETED
Lidocaine Usage for Pupil Dilatation (Mydriasis)
Lead Sponsor:
Carmel Medical Center
Conditions:
Cataract
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
The purpose of this study is to determine if the mydriatic effect of intracameral lidocaine 1% is as effective as topical cyclopentolate 1% and phenylephrine 10% for achieving effective mydriasis duri...
Detailed Description
Former studied done on the effect of Intracameral lidocaine 1% compared to topical mydriatic agents for achieving effective mydriasis during phacoemulsification surgery have compared 2 different group...
Eligibility Criteria
Inclusion
- cataract
- men and women
- can read and sign informed consent form
Exclusion
- sensitivity to Lidocaine
- sensitivity to Ephrine
- any other ocular surgeries
- diseases like Adie's pupil, Horner syndrome
Key Trial Info
Start Date :
December 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01170130
Start Date
December 1 2009
End Date
October 1 2012
Last Update
February 24 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.